Bryant Furlow
Evolving research improves lymphoma diagnosis, treatment
As researchers uncover biomarkers for cancer subtypes, collaboration between researchers, pathologists and physicians will improve accurate diagnosis of lymphoma subtypes.
Personalized strategies critical for childhood cancer
Next-generation gene sequencing and other advanced technologies for personalized medicine may soon identify biomarkers that will improve treatment response and long-term toxicity risks for childhood cancer patients.
Midostaurin extends survival among some AML patients: Study
AML’s genetic complexity raises concerns about long-term prospects of single mutation-targeting agents


View Results